Anesthesia for Catheter Aortic Valve ImplantATIOn Registry (AVIATOR)

August 5, 2024 updated by: N Patrick Mayr, Deutsches Herzzentrum Muenchen
In modern cardiac surgery and cardiology Transcatheter Aortic Valve Implantation (TAVI) is an emerging procedure for high-risk patients that are assumed to be otherwise inoperable. The investigators want to evaluate the specific intraoperative anesthesiologic characteristics cardiac anesthesiologists have to face during these procedures.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Michael Joner, M.D.,Prof
  • Phone Number: +49 89 1218
  • Email: joner@dhm.mhn.de

Study Locations

  • Germany
    • Bavaria
      • Munich, Bavaria, Germany, D-80636
        • Recruiting
        • Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients undergoing transcatheter aortic valve implantation (TAVI)

Description

Inclusion Criteria:

- Patients undergoing transcatheter aortic valve implantation (TAVI)

Exclusion Criteria:

- Refusal by patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative Care
Time Frame: 1 day
major critical adverse events
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Up to 10 years
Time Frame: 10 Years
all-cause mortality
10 Years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Deutsches Herzzentrum Muenchen

Investigators

  • Principal Investigator: Patrick N Mayr, M.D., Deutsches Herzzentrum München, Technische Universität München
  • Principal Investigator: Michael Joner, MD, Prof., Deutsches Herzzentrum München, Technische Universität München

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

June 27, 2011

First Submitted That Met QC Criteria

July 8, 2011

First Posted (Estimated)

July 11, 2011

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 5, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GE DHM-AN-OR-2011/04 (Other Identifier: Deutsches Herzzentrum München)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe